Delivery Order SPE2DB22D1106-SPE2DB24FDNA3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorescein Sodium 10% vial (5 mL). The contract is a firm-fixed-price Delivery Order with a ceiling value of $7,542.10 and a period of performance through June 5, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5 ml vials of 10% Fluorescein Sodium. The contract is a firm fixed-price delivery order valued at $2,218.77, with a period of performance ending on March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6EDF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,945.94 firm-fixed-price delivery order is for the supply of 4563145360 - Fluorescein Sodium 10% Vial 5ML. The award has an ultimate completion date of December 20, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a...
- This federal contract award, valued at $4,234.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D1053|SPE2DX25F6MXD) for the supply of 4568093522 - Fluorescein Sodium 10% Vial 5ML, with a firm fixed price and a performance period through May 1, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $7,473.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fluorescein Sodium 10% Vial 5ml, with an ultimate completion date of November 12, 2025. This non-set-aside contract was competitively awarded on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products, specifically AK-FLUOR 10% VIAL 5ML. The contract has a Firm Fixed Price pricing type and a ceiling value of $1,255.55. The contract is not designated as a set-aside and has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Fluorometholone 0.1% eye drops in 5 ML containers. The $2,946.70 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of February 27, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluorometholone 0.1% eye drops in 5 ml bottles, with a ceiling value of $8,016.83 and a completion date of March 1, 2024. The contract is a Firm Fixed Price arrangement and does not have any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluorometholone 0.1% eye drops, a pharmaceutical product, with a ceiling value of $5,534.84 and a performance period through November 27, 2023. The contract was awarded on a firm fixed-price basis without any set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $77,578.13 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDNA3Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluorescein Sodium 10% vials in 5 ml sizes, with a total ceiling value of $7,138.82. The contract is a firm-fixed price delivery order contract with a period of performance ending on November 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/24/23 |